Baker Biotech Capital (GP), LLC Insider Trading $GEVA SYNAGEVA BIOPHARMA CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker Biotech Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Biotech Capital (GP), LLC. Baker Biotech Capital (GP), LLC is 10% Owner in PHARMACYCLICS INC ($PCYC) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in Ocera Therapeutics, Inc. ($TZYM).
Baker Biotech Capital (GP), LLC in SYNAGEVA BIOPHARMA CORP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Biotech Capital (GP), LLC: Director
Holdings: 1,736,065 shares
Latest Transaction: Jan 09 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Biotech Capital (GP), LLC in SYNAGEVA BIOPHARMA CORP
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, GHDX, TZYM, PCYC, SGEN, GEVA, VPHM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 09 2012 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Biotech Capital (GP), LL ... | Director | Grant | A | 25.18 | 187,576 | 4,723,164 | 1,736,065 | 1.5 M to 1.7 M (+12.11 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Biotech Capital (GP), LL ... | Director | Grant | A | 0.00 | 1,046,755 | 0 | 1,548,489 | 501.7 K to 1.5 M (+208.63 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Biotech Capital (GP), LL ... | Director | Grant | A | 0.00 | 127,527 | 0 | 501,734 | 374.2 K to 501.7 K (+34.08 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Biotech Capital (GP), LL ... | Director | Grant | A | 0.00 | 123,591 | 0 | 374,207 | 250.6 K to 374.2 K (+49.31 %) |
Page: 1